Karyopharm Therapeutics (KPTI) PT Lowered to $15 at SVB Leerink, Following Earnings

May 3, 2021 1:02 PM EDT
Get Alerts KPTI Hot Sheet
Price: $6.09 +0.33%

Rating Summary:
    11 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 9 | New: 24
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

SVB Leerink analyst Jonathan Chang lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $15.00 (from $22.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Earnings